[1] Russell MD, Gibson M, Zuckerman B, et al. Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study[J]. Lancet Rheumatol, 2025, 7: e44-e54. doi:10.1016/S2665-9913(24)00221-2. [2] Komatsu N, Win S, Yan M, et al. Plasma cells promote osteoclastogenesis and periarticular bone loss in autoim-mune arthritis[J]. J Clin Invest, 2021, 131: e150274. doi:10.1172/JCI150274. [3] Chen DT, Wan ZJ, Sheng XP, et al. Effects of higenamine on M1/M2 polarization and osteoclast differentiation in rheumatoid arthritis via the THBS-1/TGF-β signaling pathway[J]. Cell Signal, 2025, 134: 111905. doi:10.1016/j.cellsig.2025.111905. [4] Pourhabibi-Zarandi F, Rafraf M, Zayeni H, et al. The efficacy of curcumin supplementation on serum total antioxidant capacity, malondialdehyde, and disease activity in women with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial[J]. Phytother Res, 2024, 38: 3552-3563. doi:10.1002/ptr.8225. [5] Dai Q, Zhou D, Xu L, et al. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats[J]. Drug Des Devel Ther, 2018, 12: 4095-4105. doi:10.2147/DDDT.S175763. [6] Zhao H, Duan S, Shi Y, et al. Naru-3 inhibits inflammation, synovial hyperplasia, and neovascularization in collagen-induced arthritis in rats[J]. J Ethnopharmacol, 2023, 311:116350. doi:10.1016/j.jep.2023.116350. [7] 李刚, 胡立新, 徐昕, 等. 基于RhoA/ROCK通路研究miR-146a过表达对类风湿关节炎大鼠关节损伤的修复作用[J]. 中华骨与关节外科杂志, 2023, 16: 628-633.doi:10.3969/j.issn.2095-9958.2023.07.10. [8] Wang N, Wu W, Qiang C, et al. Protective role of collectin 11 in a mouse model of rheumatoid arthritis[J]. Arthritis Rheumatol, 2021, 73: 1430-1440. doi:10.1002/art.41696. [9] Li Y, Chen M, Yang Z, et al. β-Glucan modulates trained immunity to inhibit osteoclast differentiation via NOD2/RIPK2 signaling pathway[J]. Int Immunopharmacol, 2025, 159: 114886. doi:10.1016/j.intimp.2025.114886. [10] Tang Y, Bai Z, Qi J, et al. Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis[J]. Clin Exp Immunol, 2021, 206: 354-365. doi:10.1111/cei.13663. [11] Deng J, Fan C, Gao X, et al. Signal transducer and activator of transcription 3 hyperactivation associates with follicular helper T cell differentiation and disease activity in rheumatoid arthritis[J]. Front Immunol, 2018, 9: 1226. doi:10.3389/fimmu.2018.01226. [12] Xu Z, Shang W, Zhao Z, et al. Curcumin alleviates rheumatoid arthritis progression through the phosphatidy-linositol 3-kinase/protein kinase B pathway: an in vitro and in vivo study[J]. Bioengineered, 2022, 13: 12899-12911. doi:10.1080/21655979.2022.2078942. [13] Xiao J, Cai X, Zhou W, et al. Curcumin relieved the rheumatoid arthritis progression via modulating the linc00052/miR-126-5p/PIAS2 axis[J]. Bioengineered, 2022, 13: 10973-10983. doi:10.1080/21655979.2022.2066760. [14] Ke D, Xu H, Han J, et al. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway[J]. Biomed J, 2024, 47: 100605. doi:10.1016/j.bj.2023.100605. [15] Xin S, Liu L, Li Y, et al. Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-κB positive feedback loop[J]. Virol Sin, 2022, 37: 913-921. doi:10.1016/j.virs.2022.09.001. |